Moderna Inc. buy The Goldman Sachs Group, Inc.
Start price
28.01.25
/
50%
€41.85
Target price
28.01.26
€94.88
Performance (%)
-10.12%
End price
29.01.26
€37.62
Summary
This prediction ended on 29.01.26 with a price of €37.62. The prediction for Moderna Inc. disappointed with a performance of -10.12%. The_Goldman_Sachs_Gr has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Moderna Inc. | -10.309% | -10.309% | 73.538% |
| iShares Core DAX® | -1.424% | 8.918% | 7.311% |
| iShares Nasdaq 100 | 3.274% | 16.275% | 36.651% |
| iShares Nikkei 225® | 1.745% | 16.239% | 46.602% |
| iShares S&P 500 | 1.447% | 10.913% | 27.166% |
Comments by The_Goldman_Sachs_Gr for this prediction
In the thread Moderna Inc. diskutieren
Moderna, Inc. (NASDAQ: MRNA) had its price target lowered by analysts at The Goldman Sachs Group, Inc. from $112.00 to $99.00. They now have a "buy" rating on the stock.
Ratings data for MRNA provided by MarketBeat
In the thread Trading Moderna Inc.
Die von The_Goldman_Sachs_Gr gewählte maximale Laufzeit wurde überschritten